Literature DB >> 29398731

Quality of life among South African patients receiving antiretroviral therapy in the Western Cape Province.

Ashraf Kagee1, Bronwynè Coetzee1, Henry Steel1.   

Abstract

Compared to patients not receiving treatment, antiretroviral therapy (ART) users may experience a lower viral load, an increased CD4 count, slower disease progression, fewer opportunistic infections, and more rapid recovery time from HIV-related illnesses. As such, health related quality of life (HR-QOL) is likely to be considerably greater for ART users than patients not receiving treatment. The dearth of QOL research in sub-Saharan Africa brings into focus the need for and importance of documenting the various dimensions of well-being among persons living with HIV in this region of the world. We thus sought to report on the performance of South African patients enrolled in a public government funded antiretroviral therapy (ART) program. We administered the Functional Assessment of HIV Infection (FAHI) to a convenience sample of patients receiving ART in the Western Cape in South Africa. We used confirmatory factor analysis (CFA) and exploratory factor analysis (EFA) to determine the factor structure of the FAHI amongst South African ART users. The CFA revealed a poor model fit of the data. However the EFA factor structure closely approximated the subscales of the measure, indicating the dimensions of physical, emotional, functional, and social well-being and cognitive functioning. We identified problematic items contributing to the poor model fit and contribute to the knowledge base on QOL amongst ART users in South Africa.

Entities:  

Keywords:  Antiretroviral therapy; Confirmatory factor analysis; Quality of life

Year:  2016        PMID: 29398731      PMCID: PMC5793921          DOI: 10.1177/0081246315623237

Source DB:  PubMed          Journal:  S Afr J Psychol        ISSN: 0081-2463


  15 in total

Review 1.  A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials.

Authors:  Darren J Clayson; Diane J Wild; Paul Quarterman; Isabelle Duprat-Lomon; Maria Kubin; Stephen Joel Coons
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of life.

Authors:  D I Abrams; C Steinhart; R Frascino
Journal:  Int J STD AIDS       Date:  2000-10       Impact factor: 1.359

3.  Self-reported psychological distress associated with steroid therapy for HIV.

Authors:  T Lyons; D Berger; B Masini; G Pinna
Journal:  Int J STD AIDS       Date:  2010-12       Impact factor: 1.359

4.  Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument.

Authors:  A H Peterman; D Cella; F Mo; N McCain
Journal:  Qual Life Res       Date:  1997-08       Impact factor: 4.147

5.  An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART.

Authors:  J Jelsma; E Maclean; J Hughes; X Tinise; M Darder
Journal:  AIDS Care       Date:  2005-07

6.  Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation.

Authors:  Teri T Baldewicz; Jane Leserman; Susan G Silva; John M Petitto; Robert N Golden; Diana O Perkins; Julie Barroso; Dwight L Evans
Journal:  AIDS Behav       Date:  2004-09

7.  Factors associated with prevalence of mental disorder in people living with HIV/AIDS in South Africa.

Authors:  M Freeman; N Nkomo; Z Kafaar; K Kelly
Journal:  AIDS Care       Date:  2007-11

8.  Traditional beliefs about the cause of AIDS and AIDS-related stigma in South Africa.

Authors:  S C Kalichman; L Simbayi
Journal:  AIDS Care       Date:  2004-07

9.  "I'm sorry, you're positive": a qualitative study of individual experiences of testing positive for HIV.

Authors:  Jen R Hult; Stephanie A Maurer; Judith T Moskowitz
Journal:  AIDS Care       Date:  2009-02

10.  An overview of generic health-related quality of life measures for HIV research.

Authors:  R D Hays; M F Shapiro
Journal:  Qual Life Res       Date:  1992-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.